.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The Primary Tube Versus Trabeculectomy (PTVT) Study provides long-term comparative evidence for two established glaucoma operations. At five years, mean intraocular pressure was very similar after Baerveldt tube shunt surgery and trabeculectomy with mitomycin C. The cumulative probability of failure also did not differ significantly between the treatment groups. One clinically relevant difference was medication burden: patients in the trabeculectomy group required fewer glaucoma medications at five years. The findings are useful when counseling patients with medically uncontrolled glaucoma because they show that both procedures can achieve substantial and durable pressure lowering, but their postoperative profiles differ. Tube shunts may be attractive in eyes where prior surgery or conjunctival considerations influence the choice, while trabeculectomy can achieve excellent pressure control with a lower medication burden in appropriately selected eyes. The study reinforces that glaucoma surgery decisions should be individualized rather than framed around one universally superior procedure. Surgeon experience, target IOP, conjunctival status, prior operations, scarring risk, and the patient's tolerance for postoperative follow-up all remain important determinants of the final surgical strategy.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The Primary Tube Versus Trabeculectomy (PTVT) Study provides long-term comparative evidence for two established glaucoma operations. At five years, mean intraocular pressure was very similar after Baerveldt tube shunt surgery and trabeculectomy with mitomycin C. The cumulative probability of failure also did not differ significantly between the treatment groups. One clinically relevant difference was medication burden: patients in the trabeculectomy group required fewer glaucoma medications at five years. The findings are useful when counseling patients with medically uncontrolled glaucoma because they show that both procedures can achieve substantial and durable pressure lowering, but their postoperative profiles differ. Tube shunts may be attractive in eyes where prior surgery or conjunctival considerations influence the choice, while trabeculectomy can achieve excellent pressure control with a lower medication burden in appropriately selected eyes. The study reinforces that glaucoma surgery decisions should be individualized rather than framed around one universally superior procedure. Surgeon experience, target IOP, conjunctival status, prior operations, scarring risk, and the patient's tolerance for postoperative follow-up all remain important determinants of the final surgical strategy.
last month
Preclinical findings demonstrate that ginsenoside Ra1 preserves vascular integrity and attenuates multi-organ injury during sepsis by targeting non-muscle myosin heavy chain IIA (NMMHC IIA) and dampening TLR4/NF-κB/NLRP3 inflammatory signaling.
2 days back
An all-printed immunosensing microchip detects urinary sFlt-1 in just 10 minutes with 3.61 pg/mL sensitivity. By leveraging photonic bandgap engineering, this low-cost, cleanroom-free platform provides non-invasive preeclampsia screening, offering substantial benefits for point-of-care obstetric triage.
3 days back
Wearable ultrasound patches are transforming healthcare by shifting medicine from episodic evaluations to continuous monitoring. Discover how flexible acoustic transducers advance cardiovascular tracking, musculoskeletal imaging, neuromodulation, and on-demand closed-loop theranostics.
3 days back
A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
Last week
Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
Last week
